1-20 of 160
Marina Liberati
Close
Sort by
Journal Articles

Rituximab and Lenalidomide (R 2 ) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)

Carola Boccomini, Barbara Botto, Andrea Evangelista, Vittorio Ruggero Zilioli, Antonella Anastasia, Federica Cavallo, Francesco Merli, Manuela Zanni, Monica Tani, Annalisa Chiarenza, Anna Marina Liberati, Annarita Conconi, Paolo Corradini, Alessia Bari, Giorgia Annechini, Gianluca Gaidano, Michele Spina, Roberto Sartori, Claudia Castellino, Benedetta Puccini, Annalisa Arcari, Sara Bigliardi, Giorgia Matta, Michele Merli, Donato Mannina, Dario Marino, Piero Galieni, Fabrizio Ciambelli, Gerardo Musuraca, Chiara Bottelli, Cristina Muzi, Simone Ferrero, Stefano Luminari, Marco Ladetto, Giovannino Ciccone, Umberto Vitolo
Journal: Blood
Blood (2023) 142 (Supplement 1): 982.
https://doi.org/10.1182/blood-2023-174901
Published: 2023
Journal Articles

Estimates of Survival and Life Expectancy with Tafasitamab Plus Lenalidomide in the L-Mind Study Compared with Real-World Standard-of-Care for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Johannes Duell, Martin Dreyling, Gianluca Gaidano, Nagesh Kalakonda, Eva Maria Gonzalez Barca, Anna Marina Liberati, Zsolt Nagy, Daniel Moik, Mirko Vukcevic, Aasim Amin, Abhishek Bakuli
Journal: Blood
Blood (2023) 142 (Supplement 1): 6286.
https://doi.org/10.1182/blood-2023-174043
Published: 2023
Journal Articles

Early-Stage Follicular Lymphoma: Learnings from the Final Analysis of the Multicenter Phase II FIL (Fondazione Italiana Linfomi) “Miro” Trial, Combining Local Radiotherapy and MRD-Driven Immunotherapy

Alessandro Pulsoni, Maria Elena Tosti, Simone Ferrero, Stefano Luminari, Alessandra Dondi, Anna Marina Liberati, Natalia Cenfra, Daniela Renzi, Manuela Zanni, Carola Boccomini, Andrés José María Ferreri, Sara Rattotti, Vittorio Ruggero Zilioli, Patrizia Bernuzzi, Silvia Bolis, Gerardo Musuraca, Luca Nassi, Tommasina Perrone, Caterina Stelitano, Antonella Anastasia, Paolo Corradini, Giovanni Partesotti, Francesca Re, Emanuele Cencini, Clara Mannarella, Donato Mannina, Anna Lia Molinari, Monica Tani, Giorgia Annechini, Giovanni Manfredi Assanto, Lavinia Grapulin, Anna Guarini, Marzia Cavalli, Lucia Anna De Novi, Riccardo Bomben, Elena Ciabatti, Barbara Mantoan, Daniela Drandi, Irene Della Starza, Luca Arcaini, Umberto Ricardi, Valter Gattei, Sara Galimberti, Marco Ladetto, Robin Foà, Ilaria Del Giudice
Journal: Blood
Blood (2023) 142 (Supplement 1): 4399.
https://doi.org/10.1182/blood-2023-182946
Published: 2023
Journal Articles

36-Month Follow-up Results of the Gimema ‘Veritas’ Trial of Front-Line Venetoclax and Rituximab (VenR) in Young and Fit Patients with Chronic Lymphocytic Leukemia and an Adverse Biologic Profile

Francesca Romana Mauro, Irene Della Starza, Monica Messina, Gianluigi Reda, Livio Trentin, Marta Coscia, Paolo Sportoletti, Lorella Orsucci, Valentina Arena, Gianluca Gaidano, Roberto Marasca, Roberta Murru, Luca Laurenti, Caterina Stelitano, Donato Mannina, Fiorella Ilariucci, Massimo Massaia, Gian Matteo Rigolin, Lydia Scarfo, Monia Marchetti, Luciano Levato, Monica Tani, Annalisa Arcari, Gerardo Musuraca, Marina Deodato, Piero Galieni, Valeria Belsito Patrizi, Daniela Gottardi, Anna Marina Liberati, Annamaria Giordano, Maria Chiara Molinari, Sara Pepe, Costanza Andriola, Veronica Mattiello, Andrea Visentin, Candida Vitale, Francesco Albano, Antonino Neri, Maria Stefania De Propris, Mauro Nanni, Ilaria Del Giudice, Anna Guarini, Paola Fazi, Marco Vignetti, Alfonso Piciocchi, Antonio Cuneo, Robin Foà
Journal: Blood
Blood (2023) 142 (Supplement 1): 1905.
https://doi.org/10.1182/blood-2023-181597
Published: 2023
Journal Articles

Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study

Clinical Trials & Observations
Guido Gini, Monica Tani, Alessandra Tucci, Luigi Marcheselli, Marina Cesaretti, Monica Bellei, Anna Pascarella, Filippo Ballerini, Mauro Petrini, Francesco Merli, Attilio Olivieri, Francesco Lanza, Ombretta Annibali, Vittorio Ruggero Zilioli, Anna Marina Liberati, Maria Chiara Tisi, Annalisa Arcari, Dario Marino, Gerardo Musuraca, Vincenzo Pavone, Alberto Fabbri, Samantha Pozzi, Donato Mannina, Caterina Plenteda, Melania Celli, Stefano Luminari
Journal: Blood
Blood (2023) 142 (17): 1438–1447.
https://doi.org/10.1182/blood.2022019173
Published: 2023
Includes: Supplemental data
Journal Articles

Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study

Maria-Victoria Mateos, Jesús San-Miguel, Michele Cavo, Joan Bladé Creixenti, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Ludek Pour, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Huiling Pei, Maria Krevvata, Robin Carson, Fredrik Borgsten, Meletios A. Dimopoulos
Journal: Blood
Blood (2022) 140 (Supplement 1): 10157–10159.
https://doi.org/10.1182/blood-2022-163347
Published: 2022
Journal Articles

L-Mind: A Safety and Efficacy Analysis of Tafasitamab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Receiving Treatment for at Least 2 Years

Johannes Duell, Wojciech Jurczak, Anna Marina Liberati, Janusz Halka, Esther Pena Carbó, Pau Abrisqueta Costa, Kami J. Maddocks, Martin Dreyling, Andreas Rosenwald, Abhishek Bakuli, Aasim Amin, Konstantin Gurbanov, Gilles Salles
Journal: Blood
Blood (2022) 140 (Supplement 1): 6596–6598.
https://doi.org/10.1182/blood-2022-159983
Published: 2022
Journal Articles

Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

Massimo Breccia, Paola Guglielmelli, Francesco Mendicino, Alessandra Malato, Giuseppe A. Palumbo, Carmine Selleri, Daniela Cilloni, Patrizio Mazza, Sergio Siragusa, Elisabetta Abruzzese, Maurizio Martelli, Giulia Benevolo, Erminia Rinaldi, Monica Crugnola, Serena Rupoli, Vincenzo Pavone, Massimiliano Bonifacio, Fabrizio Pane, Giuseppe Carli, Maria Langella, Marta Bruno Ventre, Elena Maria Elli, Stefana Impera, Anna Marina Liberati, Nicola Di Renzo, Bruno Martino, Paolo Sportoletti, Mario Tiribelli, Gianni Binotto, Mario Annunziata, Mauro Di Ianni, Giorgio La Nasa, Antonietta Pia Falcone, Rossana Leanza, Antonio Volpe, Filippo Gherlinzoni, Valerio De Stefano, Daniele Vallisa, Sabrina Leonetti Crescenzi, Francesco Cavazzini, Alessandra Ricco, Carmela Barberio, Alessandra Misto, Francesco Passamonti, Francesca Palandri
Journal: Blood
Blood (2022) 140 (Supplement 1): 9688–9690.
https://doi.org/10.1182/blood-2022-157914
Published: 2022
Journal Articles

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma

Clinical Trials & Observations
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, Daniela Drandi, Gian Maria Zaccaria, Beatrice Alessandria, Marco Ghislieri, Martina Ferrante, Andrea Evangelista, Barbara Mantoan, Gabriele De Luca, Piero Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, Claudia Castellino, Vincenzo Pavone, Mario Petrini, Francesca Re, Stefan Hohaus, Gerardo Musuraca, Nicola Cascavilla, Chiara Ghiggi, Anna Marina Liberati, Sergio Cortelazzo, Marco Ladetto
Journal: Blood
Blood (2022) 140 (12): 1378–1389.
https://doi.org/10.1182/blood.2021014270
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical Outcomes in Patients (Pts) with Dose Reduction of Selinexor in Combination with Bortezomib, and Dexamethasone (XVd) in Previously Treated Multiple Myeloma from the Boston Study

Sundar Jagannath, Thierry Facon, Ashraf Z. Badros, Moshe Levy, Philippe Moreau, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Iryna Kriachok, Maria Gavriatopoulou, Halyna Pylypenko, Holger W Auner, Xavier Leleu, Vadim Doronin, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Chris P. Venner, Mamta Garg, Mercedes Gironella Mesa, Artur Jurczyszyn, Tadeusz Robak, Monica Galli, Craig Thomas Wallington-Beddoe, Atanas Radinoff, Galina Salogub, Don Stevens, Supratik Basu, Anna Marina Liberati, Hang Quach, Veselina S Goranova Marinova, Jelena Sreten Bila, Eirini Katodritou, Andrew DeCastro, Yi Chai, Dane R. Van Domelen, Moran Mishal, Ohad S. Bentur, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Sebastian Grosicki, Paul G. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 3793.
https://doi.org/10.1182/blood-2021-146003
Published: 2021
Journal Articles

Lenalidomide and Rituximab (ReRi) As Front-Line Chemo-Free Therapy for Elderly Frail Patients with Diffuse Large B-Cell Lymphoma. a Phase II Study of the Fondazione Italiana Linfomi (FIL)

Guido Gini, Monica Tani, Renato Bassan, Alessandra Tucci, Filippo Ballerini, Michela Sampaolo, Francesco Merli, Francesca Re, Attilio Olivieri, Mauro Petrini, Ombretta Annibali, Anna Marina Liberati, Carlo Visco, Annalisa Arcari, Sergio Storti, Alberto Fabbri, Gerardo Musuraca, Vittorio Ruggero Zilioli, M. Christina Cox, Stefano Luminari
Journal: Blood
Blood (2021) 138 (Supplement 1): 305.
https://doi.org/10.1182/blood-2021-148380
Published: 2021
Journal Articles

Progression-Free Survival Outcomes By Response Status for Bortezomib, Melphalan, and Prednisone with or without Daratumumab in Newly Diagnosed Multiple Myeloma: Pooled Subgroup Analysis of Octans and Alcyone

Jianxiang Wang, Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, CS Chim, Paula Rodriguez-Otero, Anna Marina Liberati, Hiroyuki Takamatsu, Jae Hoon Lee, Meletios A. Dimopoulos, Susan Wroblewski, Robin Carson, Ming Qi, Jianping Wang, Yang Song, Bin Jia, Xue Yang, Wenyu Liu, Yunan Li, Renyi Zhang, Jian Hou
Journal: Blood
Blood (2021) 138 (Supplement 1): 1648.
https://doi.org/10.1182/blood-2021-148937
Published: 2021
Journal Articles

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone

Paula Rodriguez-Otero, Mario Boccadoro, Roman Hajek, MD, Tomoaki Fujisaki, MD, Jae Hoon Lee, MD PhD, Joaquin Martinez-Lopez, MD, Paulo Lucio, MD PhD, Zsolt Nagy, MD PhD, Ganna Usenko, MD, Anna Marina Liberati, MD, Mihaela Lazaroiu, MD, Dariusz Woszczyk, MDPhD, Hiroyuki Takamatsu, MDPhD, Joanna Romejko-Jarosinska, Stefan Tobias Knop, Astrid Pavlovsky, MD, Cecily Forsyth, FRACP, FRCPA, MBBS, Takayuki Ishikawa, MD PhD, Katharine S. Gries, PhD PharmD, Huiling Pei, PhD, Anupa Kudva, MD, Jon Ukropec, PhD, Susan Wroblewski, PhD, Robin Carson, MD BA, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136145
Published: 2020
Journal Articles

The Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 10 9 /L to < 100 × 10 9 /L) at Baseline

Paola Guglielmelli, MD, Jean-Jacques Kiladjian, MD PhD, Alessandro M. Vannucchi, MD, Ming-hui Duan, MD, Haitao Meng, MD PhD, Ling Pan, MD PhD, Guangsheng He, MD PhD, Srdan Verstovsek, MD PhD, Françoise Boyer-Perrard, MD, Fiorenza Barraco, MD, Dietger Niederwieser, MD PhD, Anna Marina Liberati, MD, Claire Harrison, DM, FRCP, FRCPath, Pantelia Roussou, MSc, Monika Wroclawska, MD, Kevin Majidi, Peter AW te Boekhorst, MD PhD, Heinz Gisslinger, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-137742
Published: 2020
Journal Articles

Long-Term Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Kami J. Maddocks, MD, Johannes Duell, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, Anna Marina Liberati, MD, Sven de Vos, MD PhD, Zsolt Nagy, MD PhD, Aleš Obr, MDPhD, Gianluca Gaidano, Pau Abrisqueta, MD PhD, Marc André, MD, Martin Dreyling, MD, Tobias F Menne, MD PhD FRCPath, Maren Dirnberger-Hertweck, PhD, Johannes Weirather, PhD, Sumeet Ambarkhane, MD MBBS, Gilles Salles, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–21.
https://doi.org/10.1182/blood-2020-140314
Published: 2020
Journal Articles

Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS)

Monica Bocchia, Anna Sicuranza, PhD, Paola Pacelli, Alessandra Iurlo, MD PhD, Elisabetta Abruzzese, MD, Sara Galimberti, MD PhD, Patrizia Pregno, Giovanni Caocci, MD, Isabella Capodanno, MD, Monica Crugnola, MD, Antonella Gozzini, MD, Claudio Fozza, MD, Mario Annunziata, MD, Sabina Russo, Anna Marina Liberati, Olga Mulas, Daniele Cattaneo, Adele Santoni, Vincenzo Sammartano, Federico Caroni, Donatella Raspadori
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-139306
Published: 2020
Journal Articles

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini, Monica Galli, Angelo Belotti, Elena Zamagni, Luca Bertamini, MD, Renato Zambello, Micol Quaresima, Giovanni De Sabbata, Giuseppe Pietrantuono, Mattia D'Agostino, MD, Daniela Oddolo, Andrea Capra, Anna Marina Liberati, Salvatore Palmieri, Franco Narni, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-136907
Published: 2020
Journal Articles

Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study

Michele Cavo, Francesca Gay, MD, Meral Beksac, MD, Meletios A Dimopoulos, Lucia Pantani, MD PhD, Maria Teresa Petrucci, Luca Dozza, MSc, Bronno Van Der Holt, PhD, Sonja Zweegman, MDPhD, Elena Zamagni, Giuseppe A. Palumbo, MD PhD, Francesca Patriarca, Monica Galli, Vladimir Maisnar, MD PhD MBA, Markus Hansson, MD, Angelo Belotti, Ludek Pour, MD, Paula F Ypma, MD PhD, Mariella Grasso, Sandra Croockewit, MD, Massimo Offidani, Renato Zambello, Anna Marina Liberati, MD, Niels Frost Andersen, MD PhD, Annemiek Broyl, MD PhD, Rossella Troia, PharmD, Pellegrino Musto, Heinz Ludwig, MD, Anna Maria Morelli, MD, Roman Hajek, MD, Christoph Driessen, MD, Anders Waage, MD PhD, Peter Gimsing, DO, PhD, Ulf-Henrik Mellqvist, MD PhD, Thilo Zander, MD, Mario Boccadoro, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137575
Published: 2020
Journal Articles

Ixazomib-Based Induction Followed By Single-Agent Ixazomib Maintenance in Transplant Ineligible, Newly Diagnosed Multiple Myeloma Patients: Updated Results of the EMN10-Unito Trial

Roberto Mina, MD, Alessandra Larocca, Paolo Corradini, Nicola Cascavilla, Anna Marina Liberati, Norbert Pescosta, Francesca Fazio, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Annalisa Bernardini, Delia Rota Scalabrini, Michele Cea, Renato Zambello, Anna Baraldi, Angelo Belotti, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134671
Published: 2020
Journal Articles

Risk of Early Severe Infections in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Agents: A Pooled Analysis

Francesca Bonello, Mattia D'Agostino, MD, Massimo Offidani, Maria Teresa Petrucci, Anna Marina Liberati, Francesca Patriarca, Andrea Capra, Giulia Benevolo, Gianluca Gaidano, Gregorio Barilà, Monica Galli, Elena Ponticelli, Nicola Cascavilla, Emanuele Angelucci, Stelvio Ballanti, Giuseppe Pietrantuono, Stefano Pulini, Daniele Derudas, Paolo de Fabritiis, Paolo Corradini, Concetta Conticello, Michele Cavo, Pieter Sonneveld, MD PhD, Mario Boccadoro, Sara Bringhen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-136302
Published: 2020